Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 11.84
(4.04%)
CNY 11.84
(4.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -54.8 Million CNY | -106.1% |
| 2022 | 79.44 Million CNY | -30.16% |
| 2021 | 121.93 Million CNY | -32.01% |
| 2020 | 246.39 Million CNY | 14368.01% |
| 2019 | -4.98 Million CNY | 89.55% |
| 2018 | -19.65 Million CNY | 30.13% |
| 2017 | -25.26 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -16.92 Million CNY | 5.02% |
| 2024 Q1 | -24.66 Million CNY | 70.76% |
| 2024 Q3 | -14.67 Million CNY | 13.27% |
| 2023 Q3 | -31.18 Million CNY | -226.8% |
| 2023 Q1 | 36.03 Million CNY | 24.89% |
| 2023 FY | - CNY | -106.1% |
| 2023 Q2 | -9.54 Million CNY | -126.48% |
| 2023 Q4 | -32.8 Million CNY | -5.19% |
| 2022 Q3 | 90.54 Million CNY | 556.86% |
| 2022 Q2 | -19.81 Million CNY | -348.52% |
| 2022 Q1 | -4.41 Million CNY | -190.49% |
| 2022 FY | - CNY | -30.16% |
| 2022 Q4 | 28.85 Million CNY | -68.13% |
| 2021 Q4 | 4.88 Million CNY | -97.08% |
| 2021 FY | - CNY | -32.01% |
| 2021 Q3 | 167.18 Million CNY | 1029.85% |
| 2021 Q1 | 2.29 Million CNY | -98.51% |
| 2021 Q2 | -17.97 Million CNY | -883.8% |
| 2020 FY | - CNY | 14368.01% |
| 2020 Q2 | -4.74 Million CNY | -144.29% |
| 2020 Q1 | 10.72 Million CNY | 0.0% |
| 2020 Q3 | 82.26 Million CNY | 1832.37% |
| 2020 Q4 | 153.59 Million CNY | 86.7% |
| 2019 FY | - CNY | 89.55% |
| 2018 FY | - CNY | 30.13% |
| 2017 FY | - CNY | 0.0% |